Medicinova Inc Share Price
NASDAQ: MNOV | Micro CapMedicinova Inc Stock Performance
Open $1.70 | Prev. Close $1.62 | Circuit Range N/A |
Day Range $1.70 - $1.75 | Year Range $1.20 - $1.96 | Volume 3,523 |
Average Traded $1.73 |
Medicinova Inc Share Price Today
As of 9 September 2026, Medicinova Inc's share price is $1.75. The stock opened at $1.70, compared to its previous close of $1.62. During today's trading session, Medicinova Inc's share price traded between $1.70 and $1.75, with an average price of $1.72. Over the past 52 weeks, the stock has recorded a high of $1.96 and a low of $1.20. In terms of performance, Medicinova Inc's share price has risen by 27.74% over the last six months and is up 40.56% on a year-on-year basis.
Medicinova Inc Share Price Chart
Medicinova Inc Stock Fundamentals & Key Indicators
Market Cap $85.86M | PE Ratio (TTM) -7.29 | Dividend Yield N/A |
EPS (TTM) $-0.24 | Revenue (TTM) $409657.00 | Return On Equity (TTM) -28.85% |
Profit Margin -2928.78% | Debt to Equity 0.09 | Quarterly Earnings Growth YoY -6.95% |
Medicinova Inc Quarterly Profit & Loss
All figures in USD
Medicinova Inc Annual Profit & Loss
All figures in USD
About Medicinova Inc
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company develops MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent in Phase 2b/3 clinical trial for treating neurological and other disorders, such as progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and substance dependence and addiction, as well as prevention of acute respiratory distress syndrome, and long COVID. It is also developing MN-001 (tipelukast), an orally bioavailable small molecule compound in Phase 2 clinical trial to treat fibrotic and other metabolic disorders, including nonalcoholic fatty liver disease and hypertriglycedemia. The company has a license agreement with Kyorin Pharmaceuticals for the development and commercialization of MN-166 and MN-001. MediciNova, Inc. was incorporated in 2000 and is headquartered in La Jolla, California.
Medicinova Inc Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Sep 2026 | $1.53 | $1.62 | +8.00% |
Aug 2026 | $1.32 | $1.50 | +12.78% |
Jul 2026 | $1.38 | $1.33 | +0.76% |
Jun 2026 | $1.34 | $1.32 | -3.30% |
May 2026 | $1.41 | $1.36 | -5.86% |
Apr 2026 | $1.40 | $1.45 | +5.84% |
Mar 2026 | $1.41 | $1.37 | -6.80% |
Feb 2026 | $1.67 | $1.47 | -15.52% |
Jan 2026 | $1.40 | $1.74 | +33.85% |
Dec 2025 | $1.47 | $1.30 | -10.96% |
Nov 2025 | $1.62 | $1.46 | -12.57% |
Oct 2025 | $1.25 | $1.67 | +34.14% |
MNOV Share Price FAQs
What is Medicinova Inc share price today?
What is the 52 week high and 52 week low of Medicinova Inc stock?
What is MNOV's market capitalisation today?
What is MNOV's net income for the last quarter?
What is the 5 year returns of MNOV?
What is the high & low stock price of MNOV today?
Can I buy MNOV shares in India?